VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EBMT 2020 | Updates from JULIET: correlative analyses and clinical characteristics associated with efficacy

Edmund Waller, MD, PhD, FACP, of the Division of Hematology/Oncology, Emory Clinic, Atlanta, GA, updates us on the correlative analyses of patients and clinical characteristics associated with efficacy in the JULIET trial (NCT02445248), a Phase II evaluating tisagenlecleucel in adult relapsed/refractory diffuse large B-cell lymphoma. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter